摘要
目的:探索高敏感格拉斯哥评分(high-sensitivity modified Glasgow prognostic score, hs-mGPS)与急性射血分数保留型心力衰竭(heart failure with preserved ejection fraction, HFpEF)住院患者长期预后的关联性。方法:从重大慢病国家注册登记研究心力衰竭前瞻队列中选取HFpEF住院患者,纳入有基线白蛋白和高敏C反应蛋白(high-sensitivity C-reactive protein, hs-CRP)检测结果的患者,计算其hs-mGPS评分。依据hs-mGPS评分,将所纳入患者分为3组:0分组(hs-CRP≤3 mg/L)、1分组(hs-CRP>3 mg/L且白蛋白≥35 g/L)、2分组(hs-CRP>3 mg/L且白蛋白<35 g/L),探索HFpEF患者的hs-mGPS评分与长期全因死亡及心血管死亡的关联性。结果:共纳入1 575例急性HFpEF患者,中位年龄71(63,79)岁,女性占比50.7%;0分组656例(41.6%),1分组680例(43.2%),2分组239例(15.2%)。出院后患者的中位随访时间为4.54(4.09,4.39)年,642例(40.8%)患者发生全因死亡,其中400例(25.4%)发生心血管死亡。多因素Cox分析显示,1分组与2分组患者发生全因死亡风险分别是0分组患者的1.28倍(HR=1.28,95%CI:1.07~1.53,P<0.01)和2.21倍(HR=2.21,95%CI:1.77~2.76,P<0.01);此外,2分组患者发生心血管死亡风险是0分组患者的2.32倍(HR=2.32,95%CI:1.75~3.07,P<0.01)。结论:hs-mGPS与急性HFpEF住院患者的长期预后密切相关,其评分越高,出院后全因死亡与心血管死亡风险也越高。
Objective To analyze the relationship between high-sensitivity modified Glasgow prognostic score(hs-mGPS)and long-term death after discharge for heart failure with preserved ejection fraction(HFpEF).Methods Data were obtained from the patients hospitalized for acute HFpEF in the China Patient-centered Evaluative Assessment of Cardiac Events(PEACE)-Prospective Heart Failure Study.Patients with high-sensitivity C-reactive protein(hs-CRP)and albumin data were enrolled in this analysis.Patients were divided into hs-mGPS=0 group(hs-CRP≤3 mg/L),hs-mGPS=1 group(hs-CRP>3 mg/L and albumin≥35 g/L),hs-mGPS=2 group(hs-CRP>3 mg/L and albumin<35 g/L).We analyzed the association between hs-mGPS and risks of long-term all-cause death and cardiovascular death in patients with HFpEF.Results The study included 1575 acute HFpEF patients;the median age was 71(63,79)years,and 50.7%were women.There were 656(41.6%)patients in the hs-mGPS=0 group,680(43.2%)in the hs-mGPS=1 group,and 239(15.2%)in the hs-mGPS=2 group.The median follow-up time was 4.54(4.09,4.39)years.A total of 642(40.8%)patients died,among whom 400(24.4%)died for cardiovascular reasons.In multivariable Cox analyses,the risk of all-cause death in the hs-mGPS=1 and hs-mGPS=2 group were 1.28 times(HR=1.28,95%CI:1.07-1.53,P<0.01)and 2.21 times(HR=2.21,95%CI:1.77-2.76,P<0.01)than that in the hs-mGPS=0 group.Besides,the risk of cardiovascular death in the hs-mGPS=2 group was 2.32 times(HR=2.32,95%CI:1.75-3.07,P<0.01)than that in the hs-mGPS=2 group.Conclusion hs-mGPS is associated with prognosis in patients with acute HFpEF,and increasing hs-mGPS indicates higher risks of all-cause death and cardiovascular death.
作者
于炎武
蒲博轩
赫广达
李京阔
雷璐碧
王薇
张丽华
YU Yanwu;PU Boxuan;HE Guangda;LI Jingkuo;LEI Lubi;WANG Wei;ZHANG Lihua(National Clinical Research Center for Cardiovascular Diseases,National Center for Cardiovascular Diseases and Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,China)
出处
《临床心血管病杂志》
CAS
2024年第1期64-68,共5页
Journal of Clinical Cardiology
基金
国家科技部国家重点研发计划(No:2018YFC1312400、2018YFC1312401)
中国医学科学院医学与健康科技创新工程(No:2021-12M-1-009)。
关键词
射血分数保留型心力衰竭
高敏感格拉斯哥评分
死亡
长期预后
heart failure for preserved ventricular ejection fraction
high-sensitivity modified Glasgow prognostic score
risk of death
long term prognosis